期刊文献+

抗HBsAg抗体Fab段在大肠肝菌中的高效表达与复性 被引量:8

HIGH LEVEL EXPRESSION IN E.coli AND FOLDING OF HUMAN Fab ANTIBODY AGAINST HEPATITIS B VIRUS SURFACE ANTIGEN(HBsAg)
在线阅读 下载PDF
导出
摘要 将抗HBsAg 抗体的轻链(L)和重链Fd 段基因,分别克隆于pET20b 质粒中并分别转化到大肠肝菌BL21(DE3),LPTG诱导后,SDS-PAGE分析发现在27KD(L)和25KD(Fd)处有外源蛋白表达,表达蛋白含量分别为53% 和48% 。L链和Fd 包涵体蛋白经盐酸胍变性后,等量混合于折叠液中,L和Fd 可复性形成了约50KD的蛋白。ELISA结果表明,复性蛋白具有与HBsAg 结合的能力。抗HBsAg 抗体Fab 段在大肠杆菌中的表达与复性的成功,表明包涵体表达基因工程抗体在技术是可行的。 The genes of Fd fragment and L chain of human antibody against hepatitis B virus surface antigen(HBsAg) were cloned into plasmid pET 20b. The resultant plasmids of pETFd and pETL were transformed into E.coli BL21(DE3) respectively, resulting in production of a 25KD and a 27KD protein by the induction with IPTG. The expression level of Fd and L protein was 48% and 53%. After Fd fragment and L chain inclusion bo dies were solubilized and combined in equal molar ratio in the refolding solution. 50 KD protein was observed by SDS PAGE and its antigenicity was confirmed by western blot. Furthermore, the binding activity to HBsAg was revealed by an ELISA. These results indicated that the inclusion strategy of producing Fab fragment was available in technology.
出处 《免疫学杂志》 CAS CSCD 北大核心 1999年第4期229-231,共3页 Immunological Journal
基金 国家"863"计划资助
关键词 抗HBSAG FAB段 表达 复性 抗体 HBsAg, Fab fragment, Expression, Folding
  • 相关文献

参考文献3

二级参考文献6

共引文献5

同被引文献49

  • 1王琰,刘群英,徐建军,王雅明,陈竞华.人抗-HBs Fab段基因的序列分析及表达[J].中华微生物学和免疫学杂志,1995,15(5):304-307. 被引量:27
  • 2何明亮,李载平.基因工程抗体的性质及应用前景[J].细胞生物学杂志,1995,17(3):112-117. 被引量:4
  • 3韩焕兴,孔宪涛.人源抗HBsAg单克隆抗体组合文库的建立[J].中国免疫学杂志,1996,12(5):299-302. 被引量:7
  • 4萨姆布鲁克J 金冬雁等(译).分子克隆实验指南(第2版)[M].北京:科学出版社,1999..
  • 5Janowicz Z A, Melber K, Merkelbach, et al, Simultaneous expression of the S and L surface antigen of hepatitis B and formation of mixed particle in methylotrophic yeast Hansenula polymorpha [ J]. Yeast, 1999, 7 : 431 - 433.
  • 6Sambrook J, Pritsch E F, Maniais T. Molecular cloning: A laboratory manual [ M]. New York: Cold Spring Harbor laboratory Press, 1989.
  • 7James S H, Douglas L, Meredith M H, et al, Protein engineering of antibody bingding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli [ J ], Proc Natl Acad Sci USA, 1988, 85:5 879-5 883.
  • 8萨姆布鲁克J 金冬雁(译).分子克隆实验指南[M].北京:科学出版社,1999.304-314.
  • 9Zebedee S L, Barbas C F, Hom Y L et al. Human combination antibody libraries to hepatitis B surface antigen. Proc Nalt Acad Sci USA ,1992, 89:3175~3179
  • 10Sowyer L A. Antibodies for the prevention and treatment of virail disease. Antiviral Reasearch, 2000, 47: 57~77

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部